How Fed. Circ. Is Applying Section 101 To Drug Patents
Between 2010 and 2014, the U.S. Supreme Court issued four decisions on patent subject matter eligibility under Title 35 of the U.S. Code, Section 101 — Bilski v. Kappos,[1] Mayo Collaborative...To view the full article, register now.
Already a subscriber? Click here to view full article